Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. [electronic resource]
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov 1996
- 1853-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0161-5505
Antibodies, Bispecific--therapeutic use Carcinoma, Medullary--diagnostic imaging Carcinoma, Small Cell--diagnostic imaging Haptens Humans Iodine Radioisotopes--therapeutic use Lung Neoplasms--diagnostic imaging Radiation Dosage Radioimmunotherapy Radionuclide Imaging Radiotherapy Dosage Thyroid Neoplasms--diagnostic imaging